A. Hoos et al., Characterization of molecular abnormalities in human fibroblastic neoplasms: A model for genotype-phenotype association in soft tissue tumors, CANCER RES, 61(7), 2001, pp. 3171-3175
Desmoid tumors and fibrosarcomas (FS) are part of a wide spectrum of disord
ered fibroblastic growth that display striking clinical and phenotypic diff
erences. This study was designed to characterize molecular abnormalities th
at are associated with these differences and to determine their clinical re
levance. A cohort of 24 desmoid tumors and 25 low-grade (LG) and 14 high-gr
ade (HG) FS that were clinically and pathologically well characterized was
analyzed for alterations in expression of Ki-67, Bcl-2, retinoblastoma gene
product (pRB), and p,53 by immunohistochemistry, LG-FS and HG-PS showed ab
normal expression of Ki-67 (32 versus 86%), Bcl-2 (48 versus 57%), and pRB
(56 versus 93%), In contrast, desmoid tumors showed a normal phenotype with
these markers. pj3 overexpression was identified in 20% of LG-FS and in 29
% of HG-FS cases hut only in 4% of desmoid tumors. There was an increasing
trend in the proportion of abnormal expression of Ki-67, Bcl-2, pRB, and p5
3 with the increase of tumor aggressiveness from desmoid tumors to LG-FS to
HG-FS, The molecular differences between tumor entities were highly statis
tically significant (P < 0.01), Significant associations between abnormal e
xpression of pRB and recurrence-free survival of LG-FS patients (P = 0.05)
and between Ki-67 overexpression and recurrence-free survival for tumors of
25 cm were observed (P = 0.02), The demonstrated differences of molecular
alterations in HG-FS, LG-FS, and desmoids appear to be related to biologica
l aggressiveness of such tumors, and they might be useful to differentiate
between histologically similar cases of desmoid tumors and LG-FS, pRB and K
i-67 status may be useful to predict recurrence in certain subsets of patie
nts.